☰

Christos A. Kyratsous, Ph.D. - Publications

Affiliations: 
2009 Columbia University, New York, NY 
Area:
Microbiology
Tree Info Similar researchers PubMed Report error

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Baum A, Ajithdoss D, Copin R, Zhou A, Lanza K, Negron N, Ni M, Wei Y, Mohammadi K, Musser B, Atwal GS, Oyejide A, Goez-Gazi Y, Dutton J, Clemmons E, ... ... Kyratsous CA, et al. REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters. Science (New York, N.Y.). PMID 33037066 DOI: 10.1126/science.abe2402  0.32
2020 Yurkovetskiy L, Wang X, Pascal KE, Tomkins-Tinch C, Nyalile TP, Wang Y, Baum A, Diehl WE, Dauphin A, Carbone C, Veinotte K, Egri SB, Schaffner SF, Lemieux JE, Munro JB, ... ... Kyratsous CA, et al. Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant. Cell. PMID 32991842 DOI: 10.1016/J.Cell.2020.09.032  0.465
2020 Simões EAF, Forleo-Neto E, Geba GP, Kamal M, Yang F, Cicirello H, Houghton MR, Rideman R, Zhao Q, Benvin SL, Hawes A, Fuller ED, Wloga E, Pizarro JMN, Munoz FM, ... ... Kyratsous CA, et al. Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32897368 DOI: 10.1093/Cid/Ciaa951  0.391
2020 Yurkovetskiy L, Pascal KE, Tompkins-Tinch C, Nyalile T, Wang Y, Baum A, Diehl WE, Dauphin A, Carbone C, Veinotte K, Egri SB, Schaffner SF, Lemieux JE, Munro J, Sabeti PC, ... Kyratsous C, et al. SARS-CoV-2 Spike protein variant D614G increases infectivity and retains sensitivity to antibodies that target the receptor binding domain. Biorxiv : the Preprint Server For Biology. PMID 32637944 DOI: 10.1101/2020.07.04.187757  0.423
2020 Baum A, Fulton BO, Wloga E, Copin R, Pascal KE, Russo V, Giordano S, Lanza K, Negron N, Ni M, Wei Y, Atwal GS, Murphy AJ, Stahl N, Yancopoulos GD, ... Kyratsous CA, et al. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science (New York, N.Y.). PMID 32540904 DOI: 10.1126/Science.Abd0831  0.36
2020 Hansen J, Baum A, Pascal KE, Russo V, Giordano S, Wloga E, Fulton BO, Yan Y, Koon K, Patel K, Chung KM, Hermann A, Ullman E, Cruz J, Rafique A, ... ... Kyratsous CA, et al. Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Science (New York, N.Y.). PMID 32540901 DOI: 10.1126/Science.Abd0827  0.364
2019 Cruz JW, Damko E, Modi B, Tu N, Meagher K, Voronina V, Gartner H, Ehrlich G, Rafique A, Babb R, Aneja P, Potocky TB, D' Orvilliers A, Coppi A, E SY, ... ... Kyratsous CA, et al. A novel bispecific antibody platform to direct complement activity for efficient lysis of target cells. Scientific Reports. 9: 12031. PMID 31427700 DOI: 10.1038/S41598-019-48461-1  0.342
2018 Saphire EO, Schendel SL, Fusco ML, Gangavarapu K, Gunn BM, Wec AZ, Halfmann PJ, Brannan JM, Herbert AS, Qiu X, Wagh K, He S, Giorgi EE, Theiler J, Pommert KBJ, ... ... Kyratsous CA, et al. Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection. Cell. 174: 938-952.e13. PMID 30096313 DOI: 10.1016/J.Cell.2018.07.033  0.424
2018 de Wit E, Feldmann F, Okumura A, Horne E, Haddock E, Saturday G, Scott D, Erlandson KJ, Stahl N, Lipsich L, Kyratsous CA, Feldmann H. Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets. Antiviral Research. PMID 29885377 DOI: 10.1016/J.Antiviral.2018.06.006  0.365
2018 Pascal KE, Dudgeon D, Trefry JC, Anantpadma M, Sakurai Y, Murin CD, Turner HL, Fairhurst J, Torres M, Rafique A, Yan Y, Badithe A, Yu K, Potocky T, Bixler SL, ... ... Kyratsous CA, et al. Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in non-human primates. The Journal of Infectious Diseases. PMID 29860496 DOI: 10.1093/Infdis/Jiy285  0.362
2016 Coleman CM, Sisk JM, Halasz G, Zhong J, Beck SE, Matthews KL, Venkataraman T, Rajagopalan S, Kyratsous CA, Frieman MB. CD8+ T cells and Macrophages Regulate Pathogenesis in a Mouse Model of MERS-CoV Disease. Journal of Virology. PMID 27795435 DOI: 10.1128/Jvi.01825-16  0.36
2016 Ramanathan A, Gusarova V, Stahl N, Gurnett-Bander A, Kyratsous CA. Alirocumab, a Therapeutic Human Antibody to PCSK9, Does Not Affect CD81 Levels or Hepatitis C Virus Entry and Replication into Hepatocytes. Plos One. 11: e0154498. PMID 27115873 DOI: 10.1371/Journal.Pone.0154498  0.333
2015 Pascal KE, Coleman CM, Mujica AO, Kamat V, Badithe A, Fairhurst J, Hunt C, Strein J, Berrebi A, Sisk JM, Matthews KL, Babb R, Chen G, Lai KV, Huang TT, ... ... Kyratsous CA, et al. Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection. Proceedings of the National Academy of Sciences of the United States of America. PMID 26124093 DOI: 10.1073/Pnas.1510830112  0.377
2013 Xanthopoulos K, Lagoudaki R, Kontana A, Kyratsous C, Panagiotidis C, Grigoriadis N, Yiangou M, Sklaviadis T. Immunization with recombinant prion protein leads to partial protection in a murine model of TSEs through a novel mechanism. Plos One. 8: e59143. PMID 23554984 DOI: 10.1371/Journal.Pone.0059143  0.362
2012 Kyratsous CA, Panagiotidis CA. Heat-shock protein fusion vectors for improved expression of soluble recombinant proteins in Escherichia coli. Methods in Molecular Biology (Clifton, N.J.). 824: 109-29. PMID 22160895 DOI: 10.1007/978-1-61779-433-9_5  0.424
2010 Walters MS, Kyratsous CA, Silverstein SJ. The RING finger domain of Varicella-Zoster virus ORF61p has E3 ubiquitin ligase activity that is essential for efficient autoubiquitination and dispersion of Sp100-containing nuclear bodies. Journal of Virology. 84: 6861-5. PMID 20392849 DOI: 10.1128/Jvi.00335-10  0.644
2009 Kyratsous CA, Walters MS, Panagiotidis CA, Silverstein SJ. Complementation of a herpes simplex virus ICP0 null mutant by varicella-zoster virus ORF61p. Journal of Virology. 83: 10637-43. PMID 19656893 DOI: 10.1128/Jvi.01144-09  0.685
2009 Kyratsous CA, Silverstein SJ, DeLong CR, Panagiotidis CA. Chaperone-fusion expression plasmid vectors for improved solubility of recombinant proteins in Escherichia coli. Gene. 440: 9-15. PMID 19328840 DOI: 10.1016/J.Gene.2009.03.011  0.611
2009 Kyratsous CA, Silverstein SJ. Components of nuclear domain 10 bodies regulate varicella-zoster virus replication. Journal of Virology. 83: 4262-74. PMID 19211749 DOI: 10.1128/Jvi.00021-09  0.698
2008 Kyratsous CA, Silverstein SJ. The co-chaperone BAG3 regulates Herpes Simplex Virus replication. Proceedings of the National Academy of Sciences of the United States of America. 105: 20912-7. PMID 19088197 DOI: 10.1073/Pnas.0810656105  0.689
2008 Walters MS, Kyratsous CA, Wan S, Silverstein S. Nuclear import of the varicella-zoster virus latency-associated protein ORF63 in primary neurons requires expression of the lytic protein ORF61 and occurs in a proteasome-dependent manner. Journal of Virology. 82: 8673-86. PMID 18562514 DOI: 10.1128/Jvi.00685-08  0.651
2007 Kyratsous CA, Silverstein SJ. BAG3, a host cochaperone, facilitates varicella-zoster virus replication. Journal of Virology. 81: 7491-503. PMID 17475647 DOI: 10.1128/Jvi.00442-07  0.689
Show low-probability matches.